132 related articles for article (PubMed ID: 28293071)
1. Identification of potential leads against 4-hydroxytetrahydrodipicolinate synthase from Mycobacterium tuberculosis.
Rehman A; Akhtar S; Siddiqui MH; Sayeed U; Ahmad SS; Arif JM; Khan MK
Bioinformation; 2016; 12(11):400-407. PubMed ID: 28293071
[TBL] [Abstract][Full Text] [Related]
2. Virtual Screening of potential drug-like inhibitors against Lysine/DAP pathway of Mycobacterium tuberculosis.
Garg A; Tewari R; Raghava GP
BMC Bioinformatics; 2010 Jan; 11 Suppl 1(Suppl 1):S53. PubMed ID: 20122228
[TBL] [Abstract][Full Text] [Related]
3. Molecular Interaction of Novel Compound 2-Methylheptyl Isonicotinate Produced by Streptomyces sp. 201 with Dihydrodipicolinate Synthase (DHDPS) Enzyme of Mycobacterium tuberculosis for its Antibacterial Activity.
Singh SP; Bora TC; Bezbaruah RL
Indian J Microbiol; 2012 Sep; 52(3):427-32. PubMed ID: 23997335
[TBL] [Abstract][Full Text] [Related]
4. Shape-based virtual screening, docking, and molecular dynamics simulations to identify Mtb-ASADH inhibitors.
Kumar R; Garg P; Bharatam PV
J Biomol Struct Dyn; 2015; 33(5):1082-93. PubMed ID: 24875451
[TBL] [Abstract][Full Text] [Related]
5. Identification of the Seaweed Metabolites as Potential Anti-tubercular Agents Against Human Pantothenate synthetase: An In Silico Approach.
Arokia Rajan MS; Thirunavukkarasu R; Joseph J; Palliyath GK; Somarathinam K; Kothandan G; Subaramaniyan K; Ullah R; Rajesh RP
Curr Microbiol; 2023 Aug; 80(10):318. PubMed ID: 37578562
[TBL] [Abstract][Full Text] [Related]
6. Crystal structure and kinetic study of dihydrodipicolinate synthase from Mycobacterium tuberculosis.
Kefala G; Evans GL; Griffin MD; Devenish SR; Pearce FG; Perugini MA; Gerrard JA; Weiss MS; Dobson RC
Biochem J; 2008 Apr; 411(2):351-60. PubMed ID: 18062777
[TBL] [Abstract][Full Text] [Related]
7. Virtual screening to identify novel potential inhibitors for Glutamine synthetase of
Kumari M; Subbarao N
J Biomol Struct Dyn; 2020 Oct; 38(17):5062-5080. PubMed ID: 31755360
[TBL] [Abstract][Full Text] [Related]
8. Benzothiazole Derivative as a Novel Mycobacterium tuberculosis Shikimate Kinase Inhibitor: Identification and Elucidation of Its Allosteric Mode of Inhibition.
Mehra R; Rajput VS; Gupta M; Chib R; Kumar A; Wazir P; Khan IA; Nargotra A
J Chem Inf Model; 2016 May; 56(5):930-40. PubMed ID: 27149193
[TBL] [Abstract][Full Text] [Related]
9. Computationally Guided Identification of Novel Mycobacterium tuberculosis GlmU Inhibitory Leads, Their Optimization, and in Vitro Validation.
Mehra R; Rani C; Mahajan P; Vishwakarma RA; Khan IA; Nargotra A
ACS Comb Sci; 2016 Feb; 18(2):100-16. PubMed ID: 26812086
[TBL] [Abstract][Full Text] [Related]
10. Molecular modeling and docking studies of O-succinylbenzoate synthase of M. tuberculosis--a potential target for antituberculosis drug design.
Pulaganti M; Banaganapalli B; Mulakayala C; Chitta SK; C M A
Appl Biochem Biotechnol; 2014 Feb; 172(3):1407-32. PubMed ID: 24203275
[TBL] [Abstract][Full Text] [Related]
11. Structure-based screening and molecular dynamics simulations offer novel natural compounds as potential inhibitors of Mycobacterium tuberculosis isocitrate lyase.
Shukla R; Shukla H; Sonkar A; Pandey T; Tripathi T
J Biomol Struct Dyn; 2018 Jun; 36(8):2045-2057. PubMed ID: 28605994
[TBL] [Abstract][Full Text] [Related]
12. Virtual Screening of Novel Glucosamine-6-Phosphate Synthase Inhibitors.
Lather A; Sharma S; Khatkar A
Comb Chem High Throughput Screen; 2018; 21(3):182-193. PubMed ID: 29600755
[TBL] [Abstract][Full Text] [Related]
13. KiDoQ: using docking based energy scores to develop ligand based model for predicting antibacterials.
Garg A; Tewari R; Raghava GP
BMC Bioinformatics; 2010 Mar; 11():125. PubMed ID: 20222969
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of Mycobacterium tuberculosis dihydrodipicolinate synthase by alpha-ketopimelic acid and its other structural analogues.
Shrivastava P; Navratna V; Silla Y; Dewangan RP; Pramanik A; Chaudhary S; Rayasam G; Kumar A; Gopal B; Ramachandran S
Sci Rep; 2016 Aug; 6():30827. PubMed ID: 27501775
[TBL] [Abstract][Full Text] [Related]
15. Identification of New
Almeleebia TM; Shahrani MA; Alshahrani MY; Ahmad I; Alkahtani AM; Alam MJ; Kausar MA; Saeed A; Saeed M; Iram S
Molecules; 2021 Apr; 26(8):. PubMed ID: 33923734
[No Abstract] [Full Text] [Related]
16. Screening of antitubercular compound library identifies novel ATP synthase inhibitors of Mycobacterium tuberculosis.
Kumar S; Mehra R; Sharma S; Bokolia NP; Raina D; Nargotra A; Singh PP; Khan IA
Tuberculosis (Edinb); 2018 Jan; 108():56-63. PubMed ID: 29523328
[TBL] [Abstract][Full Text] [Related]
17. Ensemble-based high-throughput virtual screening of natural ligands using the Super Natural-II database against cell-wall protein dTDP-4-dehydrorhamnose reductase (RmlD) in
Ravichandran R; Ridzwan NFW; Mohamad SB
J Biomol Struct Dyn; 2022 Jul; 40(11):5069-5078. PubMed ID: 33382017
[TBL] [Abstract][Full Text] [Related]
18. Pharmacoinformatics analysis to identify inhibitors of Mtb-ASADH.
Kumar R; Garg P; Bharatam PV
J Biomol Struct Dyn; 2016; 34(1):1-14. PubMed ID: 25565373
[TBL] [Abstract][Full Text] [Related]
19. Structure Elucidation and Identification of Novel Lead Molecules against Sulfur Import Protein cysA of
Badineni M; Malkhed V; Rumandla L; Malikanti R; Vadija R; Mustyala KK
Curr Protein Pept Sci; 2023; 24(7):589-609. PubMed ID: 37448368
[TBL] [Abstract][Full Text] [Related]
20. Virtual screening and identification of promising therapeutic compounds against drug-resistant
Andrianov AM; Furs KV; Gonchar AV; Skrahina AM; Wang Y; Lyu LD; Tuzikov AV
J Biomol Struct Dyn; 2023 Dec; ():1-13. PubMed ID: 38088766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
